• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型人类免疫缺陷病毒包膜糖基化变化对其第三个可变结构域免疫反应性及对凝血酶敏感性的影响

Effect of changes in the glycosylation of the human immunodeficiency virus type 1 envelope on the immunoreactivity and sensitivity to thrombin of its third variable domain.

作者信息

Papandreou M J, Fenouillet E

机构信息

Faculté de Médecine Nord, CNRS, Marseille, France.

出版信息

Virology. 1998 Feb 1;241(1):163-7. doi: 10.1006/viro.1997.8930.

DOI:10.1006/viro.1997.8930
PMID:9454727
Abstract

The influence of HIV Env glycosylation on the conformation of the third variable domain (V3) of Env was studied by both deglycosylation of mature Env and the use of Env produced by recombinant systems in which alpha-glucosidase activity was inhibited by either deoxynojirimycin (DNM) or mutation. Selective deglycosylation affected anti-V3 antibody binding. The immunoreactivity and sensitivity to thrombin cleavage of V3 presented on Env produced in baby hamster kidney cells were changed by DNM treatment. In contrast, Env expressed in alpha-glucosidase I-deficient Chinese hamster ovary cells or in their parental cells treated by DNM fully retained these V3 properties. These results are discussed in relation to the inconsistent data obtained on V3 property changes resulting from Env glycosylation changes.

摘要

通过对成熟Env进行去糖基化以及使用重组系统产生的Env(其中α-葡萄糖苷酶活性被脱氧野尻霉素(DNM)或突变抑制),研究了HIV Env糖基化对Env第三个可变结构域(V3)构象的影响。选择性去糖基化影响抗V3抗体结合。DNM处理改变了在幼仓鼠肾细胞中产生的Env上呈现的V3的免疫反应性和对凝血酶切割的敏感性。相反,在α-葡萄糖苷酶I缺陷的中国仓鼠卵巢细胞或经DNM处理的其亲本细胞中表达的Env完全保留了这些V3特性。结合因Env糖基化变化而导致的V3特性变化所获得的不一致数据,对这些结果进行了讨论。

相似文献

1
Effect of changes in the glycosylation of the human immunodeficiency virus type 1 envelope on the immunoreactivity and sensitivity to thrombin of its third variable domain.1型人类免疫缺陷病毒包膜糖基化变化对其第三个可变结构域免疫反应性及对凝血酶敏感性的影响
Virology. 1998 Feb 1;241(1):163-7. doi: 10.1006/viro.1997.8930.
2
Recombinant HIV envelope expressed in an alpha-glucosidase I-deficient CHO cell line and its parental cell line in the presence of 1-deoxynojirimycin is functional.在1-脱氧野尻霉素存在的情况下,在α-葡萄糖苷酶I缺陷的中国仓鼠卵巢细胞系及其亲本细胞系中表达的重组HIV包膜具有功能。
Virology. 1997 Apr 28;231(1):89-95. doi: 10.1006/viro.1997.8505.
3
Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.在CHO糖基化突变细胞系中合成的重组HIV包膜的生物学特性。
Virology. 1996 Apr 1;218(1):224-31. doi: 10.1006/viro.1996.0182.
4
Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.利用嵌合gag-env病毒样颗粒开发艾滋病毒/艾滋病疫苗。
Biol Chem. 1999 Mar;380(3):353-64. doi: 10.1515/BC.1999.047.
5
Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.能够呈现HIV-1 V3环冠部且构象适合产生447-52D样抗体的免疫原的设计。
Biochem J. 2006 Nov 1;399(3):483-91. doi: 10.1042/BJ20060588.
6
Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolate.在对一株原发性人类免疫缺陷病毒1型分离株进行体外选择过程中,V2突变对其从一种强效中和抗V3单克隆抗体逃逸的影响
J Virol. 2007 Apr;81(8):3757-68. doi: 10.1128/JVI.01544-06. Epub 2007 Jan 24.
7
The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.HIV-1 gp120 IIIB/LAI的V3环中低轮廓丝氨酸取代对包膜蛋白免疫原性的影响。
Virology. 1998 Nov 10;251(1):59-70. doi: 10.1006/viro.1998.9392.
8
The alpha-glucosidase inhibitor 1-deoxynojirimycin blocks human immunodeficiency virus envelope glycoprotein-mediated membrane fusion at the CXCR4 binding step.
Mol Pharmacol. 2002 Jan;61(1):186-93. doi: 10.1124/mol.61.1.186.
9
Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein.葡萄糖苷酶抑制剂对1型人类免疫缺陷病毒包膜糖蛋白生物活性和免疫反应性的影响
J Gen Virol. 1991 Aug;72 ( Pt 8):1919-26. doi: 10.1099/0022-1317-72-8-1919.
10
Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization.鉴定V3区中影响CCR5利用分子结构的ENV决定簇。
J Mol Biol. 2000 Sep 15;302(2):359-75. doi: 10.1006/jmbi.2000.4076.

引用本文的文献

1
Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function.HIV-1 包膜糖蛋白缺乏复杂的 N-聚糖可保持蛋白构象和进入功能。
Virology. 2010 Jun 5;401(2):236-47. doi: 10.1016/j.virol.2010.02.019. Epub 2010 Mar 21.
2
Molecular evolution of human immunodeficiency virus env in humans and monkeys: similar patterns occur during natural disease progression or rapid virus passage.人类免疫缺陷病毒env基因在人类和猴子中的分子进化:在自然疾病进展或病毒快速传代过程中会出现相似模式。
J Virol. 2002 May;76(10):5278-84. doi: 10.1128/jvi.76.10.5278-5284.2002.
3
V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
人类免疫缺陷病毒1型SF162包膜蛋白的V2环糖基化促进该蛋白与CD4和CCR5受体的相互作用,并保护病毒免受抗V3环和抗CD4结合位点抗体的中和作用。
J Virol. 2000 Aug;74(15):6769-76. doi: 10.1128/jvi.74.15.6769-6776.2000.